Papers associated with abcc2

Limit to papers also referencing gene:

Results 1 - 18 of 18 results

Page(s): 1

Sort Newest To Oldest

Sort Oldest To Newest

	Function and Role of ATP-Binding Cassette Transporters as Receptors for 3D-Cry Toxins., Sato R, Adegawa S, Li X, Tanaka S, Endo H., Toxins (Basel). February 19, 2019; 11 (2):
	Direct reprogramming of fibroblasts into renal tubular epithelial cells by defined transcription factors., Kaminski MM, Tosic J, Kresbach C, Engel H, Klockenbusch J, Müller AL, Pichler R, Grahammer F, Kretz O, Huber TB, Walz G, Arnold SJ, Lienkamp SS., Nat Cell Biol. December 1, 2016; 18 (12): 1269-1280.
	Functional characterization of Bacillus thuringiensis Cry toxin receptors explains resistance in insects., Tanaka S, Endo H, Adegawa S, Kikuta S, Sato R., FEBS J. December 1, 2016; 283 (24): 4474-4490.
	Transport characteristics and transporter-based drug-drug interactions of TM-25659, a novel TAZ modulator., Choi MK, Kwon M, Ahn JH, Kim NJ, Bae MA, Song IS., Biopharm Drug Dispos. April 1, 2014; 35 (3): 183-94.
	Intestinal absorption mechanism of mirabegron, a potent and selective β₃-adrenoceptor agonist: involvement of human efflux and/or influx transport systems., Takusagawa S, Ushigome F, Nemoto H, Takahashi Y, Li Q, Kerbusch V, Miyashita A, Iwatsubo T, Usui T., Mol Pharm. May 6, 2013; 10 (5): 1783-94.
	Arsenic and antimony transporters in eukaryotes., Maciaszczyk-Dziubinska E, Wawrzycka D, Wysocki R., Int J Mol Sci. January 1, 2012; 13 (3): 3527-3548.
	In vitro risk assessment of AZD9056 perpetrating a transporter-mediated drug-drug interaction with methotrexate., Elsby R, Fox L, Stresser D, Layton M, Butters C, Sharma P, Smith V, Surry D., Eur J Pharm Sci. May 18, 2011; 43 (1-2): 41-9.
	Interaction of the multikinase inhibitors sorafenib and sunitinib with solute carriers and ATP-binding cassette transporters., Hu S, Chen Z, Franke R, Orwick S, Zhao M, Rudek MA, Sparreboom A, Baker SD., Clin Cancer Res. October 1, 2009; 15 (19): 6062-9.
	Use of tc-99m mebrofenin as a clinical probe to assess altered hepatobiliary transport: integration of in vitro, pharmacokinetic modeling, and simulation studies., Ghibellini G, Leslie EM, Pollack GM, Brouwer KL., Pharm Res. August 1, 2008; 25 (8): 1851-60.
	Gemfibrozil and its glucuronide inhibit the hepatic uptake of pravastatin mediated by OATP1B1., Nakagomi-Hagihara R, Nakai D, Tokui T, Abe T, Ikeda T., Xenobiotica. May 1, 2007; 37 (5): 474-86.
	Difference between pharmacokinetics of mycophenolic acid (MPA) in rats and that in humans is caused by different affinities of MRP2 to a glucuronized form., Takekuma Y, Kakiuchi H, Yamazaki K, Miyauchi S, Kikukawa T, Kamo N, Ganapathy V, Sugawara M., J Pharm Pharm Sci. January 1, 2007; 10 (1): 71-85.
	Characterization of hepatobiliary transport systems of a novel alpha4beta1/alpha4beta7 dual antagonist, TR-14035., Tsuda-Tsukimoto M, Maeda T, Iwanaga T, Kume T, Tamai I., Pharm Res. November 1, 2006; 23 (11): 2646-56.
	Expression of transporters potentially involved in the targeting of cytostatic bile acid derivatives to colon cancer and polyps., Ballestero MR, Monte MJ, Briz O, Jimenez F, Gonzalez-San Martin F, Marin JJ., Biochem Pharmacol. September 14, 2006; 72 (6): 729-38.
	OATP1B1, OATP1B3, and mrp2 are involved in hepatobiliary transport of olmesartan, a novel angiotensin II blocker., Nakagomi-Hagihara R, Nakai D, Kawai K, Yoshigae Y, Tokui T, Abe T, Ikeda T., Drug Metab Dispos. May 1, 2006; 34 (5): 862-9.
	Human organic anion-transporting polypeptide OATP-A (SLC21A3) acts in concert with P-glycoprotein and multidrug resistance protein 2 in the vectorial transport of Saquinavir in Hep G2 cells., Su Y, Zhang X, Sinko PJ., Mol Pharm. January 12, 2004; 1 (1): 49-56.
	Basolateral and canalicular transport of xenobiotics in the hepatocyte: A review., Diaz GJ., Cytotechnology. November 1, 2000; 34 (3): 225-35.
	Functional expression of the rat liver canalicular isoform of the multidrug resistance-associated protein., Madon J, Eckhardt U, Gerloff T, Stieger B, Meier PJ., FEBS Lett. April 7, 1997; 406 (1-2): 75-8.
	Mechanisms of hepatic transport and bile secretion., Erlinger S., Acta Gastroenterol Belg. January 1, 1996; 59 (2): 159-62.

Page(s): 1